Brief: Cervomed Publishes Positive Results From Ascend-Lb Phase 2A Trial

CervoMed

12/02/2024 13:19

Feb 12 (Reuters) - CervoMed Inc  CRVO.O :
    * CERVOMED PUBLISHES POSITIVE RESULTS FROM ASCEND-LB PHASE
2A
TRIAL IN PEER-REVIEWED JOURNAL THAT SUPPORTS THE THERAPEUTIC
POTENTIAL OF NEFLAMAPIMOD IN DEMENTIA WITH LEWY BODIES
    * REWIND-LB TRIAL REMAINS ON TRACK TO COMPLETE ENROLLMENT IN
FIRST
HALF OF 2024 AND REPORT PRIMARY EFFICACY RESULTS IN SECOND HALF
OF 2024

Source text for Eikon:  ID:nGNXPD8Bq 
Further company coverage:  CRVO.O 

 ((Reuters.Briefs@thomsonreuters.com;))